The Alternative Data Arms Race: What Hedge Funds Are Actually Buying

A decade ago, "alternative data" was a niche curiosity — a handful of quant funds scraping websites and buying credit card panels that no one else wanted. Today it's an $11.65 billion market projected to reach $135.72 billion by 2030, growing at a 63.4% CAGR. There are now 445+ alternative data providers, up from fewer than 100 just ten years ago.

And hedge funds are the engine driving it. They represent 68–71% of end-user revenue in the alternative data ecosystem — the dominant buyer class by a wide margin. Understanding what they're buying, how they evaluate it, and why some datasets lose their edge is essential for anyone operating in this space.

The Ten Categories That Matter

Alternative data isn't a monolith. It spans at least ten distinct categories, each with different signal characteristics, compliance profiles, and buyer segments:

Credit card data and web scraping remain the two largest categories by revenue. But the fastest growth is in sentiment/NLP — driven by the explosion of LLM capabilities — and geolocation data, which has found applications far beyond its original retail foot-traffic use case.

Who's Spending What

The spending gap between fund tiers is enormous. A sub-$500M emerging manager might allocate $100K–$500K annually to alternative data. A $50 billion multi-strategy platform can spend $50–100 million or more. The difference isn't just budget — it's organizational capacity. Large platforms have dedicated data sourcing teams that evaluate hundreds of datasets per year. Smaller funds rely on a single analyst or PM to do the same work in their spare time.

The 7-Stage Evaluation Pipeline

Large hedge funds don't buy alternative data on a whim. The evaluation process at a well-run multi-strategy platform typically follows seven stages — and most datasets don't survive past stage three:

1. Sourcing & Discovery. The data sourcing team identifies potential datasets through vendor outreach, conferences, peer recommendations, and systematic scanning of the provider landscape.
2. Initial Screening. A quick assessment of coverage, history length, update frequency, and delivery format. Does it cover the universe the fund trades? Is there enough history to backtest? This eliminates ~60% of candidates.
3. Compliance Review. Legal and compliance teams evaluate MNPI risk, data provenance, consent frameworks, and regulatory exposure. This is where many promising datasets die — particularly anything touching personal data or derived from questionable collection methods.
4. Sample Data Evaluation. The quant or research team gets a sample (typically 6–12 months of history) and runs preliminary signal tests. They're looking for correlation with known factors, coverage gaps, and basic data quality issues.
5. Full Backtest. If the sample passes, the fund requests full historical data and runs rigorous backtests. This stage can take 2–4 months. The key question: does the data generate alpha after transaction costs, and is that alpha orthogonal to what the fund already captures?
6. Trial Period. A live trial, typically 3–6 months, where the data is integrated into the research workflow but not yet used for live trading decisions. The team monitors data quality, delivery reliability, and real-time signal behavior.
7. Commercial Negotiation & Integration. If the trial succeeds, the fund negotiates pricing, exclusivity terms, and SLAs. Full integration into the production data pipeline follows.

The Signal Decay Problem

Here's the uncomfortable truth that every alternative data provider must confront: signals decay. When a dataset is novel and used by a handful of funds, it can generate meaningful alpha. But as adoption broadens — from 5 funds to 50 to 500 — the signal gets arbitraged away. The typical half-life of a broadly adopted alternative dataset's alpha contribution is 2–3 years.

This creates a paradox for data vendors. To grow revenue, you need to sell to more funds. But selling to more funds degrades the value for your existing customers. The most sophisticated buyers know this and will pay a premium for exclusivity — or at minimum, for limited distribution agreements that cap the number of hedge fund subscribers.

The vendors who navigate this best tend to do one of two things: either they continuously enhance the dataset (adding new coverage, improving granularity, reducing latency) so the product evolves faster than the signal decays, or they build platform-level products where the data is one input into a broader analytics workflow that's harder to replicate.

AI Is Changing the Game

The intersection of alternative data and AI/ML is where the most interesting developments are happening. The total AI product market in hedge funds now exceeds $10 billion annually, growing at 20–30% CAGR. Five product categories dominate:

• NLP for earnings and filings ($2B+ TAM) — Automated analysis of 10-Ks, earnings transcripts, and regulatory filings. Providers like AlphaSense, RavenPack, and Amenity Analytics.
• Sentiment analysis ($1.5B+ TAM) — Real-time processing of news, social media, and analyst commentary. Dataminr, Accern, and Bloomberg's AI-powered news analytics.
• Alternative data aggregation ($3B+ TAM) — Platforms that normalize and deliver multiple data types through a single API. Quandl (Nasdaq), YipitData, and Thinknum.
• Portfolio optimization and risk — ML-enhanced factor models, regime detection, and tail risk estimation.
• Execution intelligence — Algo optimization, market impact prediction, and TCA powered by machine learning.

The hottest emerging category: LLM-powered research assistants. These tools — offered by startups like Hebbia and Beacon, as well as incumbents building in-house — can process thousands of documents, extract structured data, and generate research summaries at a speed no human team can match. They're commanding $200K–$500K+ annual contracts, and adoption is accelerating.

The Vendor Landscape

The market has stratified into four tiers:

The most successful vendors share a common trait: they embed themselves into the daily workflow. Bloomberg's terminal is the canonical example — it's not the best at any single thing, but it's indispensable because it's where traders and PMs already live. Alternative data providers that can integrate into existing OMS/PMS/research platforms have a structural advantage over those that require users to open yet another application.

What Comes Next

Three dynamics will shape the alternative data market over the next two years:

• Consolidation is coming. With 445+ providers and many sub-scale, the market is ripe for M&A. Expect platform incumbents (Bloomberg, LSEG, S&P) and well-funded AI-native players to acquire niche data providers for their unique datasets and client relationships. YipitData's $475M Carlyle round signals the scale of capital flowing into the space.
• Compliance will tighten. The SEC's increasing scrutiny of MNPI in alternative data, combined with evolving privacy regulations (state-level CCPA variants, potential federal privacy law), will raise the compliance bar. Datasets with clean provenance and robust consent frameworks will command premium pricing.
• The "data as a service" model will win. Raw data delivery is becoming commoditized. The future belongs to vendors who deliver insights, not just data — pre-processed signals, anomaly detection, and ready-to-integrate analytics that reduce the burden on the fund's internal team.

The alternative data arms race is far from over. If anything, it's accelerating. The funds that build the best data evaluation infrastructure — and the vendors that understand the brutal economics of signal decay — will be the ones still standing when the market matures.